Thrombose unter Corona, wir müssen aktiv werden!!

• Literatur

• 1 Guan WJ, Ni ZY, Hu Y. et al Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720 . doi:10.1056/ NEJMoa2002032. Epub 2020 Feb 28. PMID: 32109013
• 2 https://www.dga-gefaessmedizin.de/fileadmin/content/PDFs/Stellungnahmen/DGA-Stellungnahme_zu_COVID-19-Infektion_und_VTE-Risiko_.pdf
• 3 https://www.awmf.org/leitlinien/detail/ll/053-054.html
• 4 Costanzo L, Failla G, Antignani PL. et al The vascular side of COVID-19 disease. Position paper of the International Union of Angiology. Int Angiol 2020; 39 (06) 445-451 . doi:10.23736/S0392-9590.20.04539-3. Epub 2020 Sep 7. PMID: 32892615
• 5 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506
• 6 Tang N, Li D, Wang X. et al Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020 [Epub ahead of print]
• 7 Klok FA, Kruip MJHA, van der Meer NJM. et al Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020 [Epub ahead of print]
• 8 Cui S, Chen S, Li X. et al Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020 [Epub ahead of print]
• 9 Tang N, Bai H, Chen X. et al Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020 [Epub ahead of print]
• 10 Thachil J, Tang N, Gando S. et al ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020 [Epub ahead of print]
• 11 Casini A, Alberio L, Angelillo-Scherrer A. et al. Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 – a Swiss consensus statement by the Working Party Hemostasis. Swiss Med Wkly 2020; 150: w20247
• 12 Marietta M, Ageno W, Artoni A. et al COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus 2020 [Epub ahead of print]
• 13 Zuo Y, Estes SK, Gandhi AA. et al Prothrombotic antiphospholipid antibodies in COVID-19. medRxiv [Preprint] 2020; . PMID: 32587992; PMCID: PMC7310650
• 14 Zuo Y, Estes SK, Ali RA. et al Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 2020; 12 (570) eabd3876 . doi:10.1126/scitranslmed.abd3876. Epub 2020 Nov 2. PMID: 33139519; PMCID: PMC7724273
• 15 https://www.aerzteblatt.de/archiv/214218/Thrombotische-Komplikationen-Gerinnungsneigung-und-COVID-19
• 16 https://www.aerzteblatt.de/archiv/216916/COVID-19-Evidenzbasierte-Therapieoptionen
• 17 Mendoza E. Krankheitsprogression in frühen Stadien von COVID-19 und Gerinnungshemmer: Die Möglichkeiten und Schwierigkeiten einer sinnvollen Untersuchung. Phlebologie 2020; 49: 199-203